NA
MDT icon

Nautilus Advisors’s Medtronic MDT Stock Holding History

Nautilus Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
3,679
-62
-2% -$5K 0.18% 135
2026
Q1 		$324K Buy
3,741
+6
+0.2% +$575 0.22% 118
2025
Q4 		$359K Sell
3,735
-105
-3% -$10.2K 0.23% 110
2025
Q3 		$366K Sell
3,840
-87
-2% -$8K 0.25% 113
2025
Q2 		$342K Sell
3,927
-8
-0.2% -$678 0.25% 112
2025
Q1 		$354K Sell
3,935
-500
-11% -$44.7K 0.29% 96
2024
Q4 		$354K Buy
+4,435
New +$384K 0.28% 96

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nautilus Advisors's MDT Position: Q2 2026 in Review

Nautilus Advisors reduced its Medtronic (MDT) stake by 1.7% in Q2 2026, selling an estimated $5K and leaving 3,679 shares worth $309K. The position accounts for 0.18% of the portfolio, ranked #135.

Nautilus Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $366K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nautilus Advisors held 3,679 shares of Medtronic worth $309K as of Q2 2026.
  • Nautilus Advisors sold 62 Medtronic shares in Q2 2026, an estimated $5K.
  • Medtronic made up 0.18% of Nautilus Advisors's portfolio in Q2 2026, its #135 holding.
  • Nautilus Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Nautilus Advisors's Medtronic position peaked at $366K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.